A Photographer’s Perspective: Malaria in Bangladesh
April 25, 2019
By Pearl Gan Malaria is one of the oldest infectious diseases known and has impacted millions of lives in Asia-Pacific….
Stephen Rogerson discusses the challenges of malaria elimination
April 25, 2019
In the lead-up to World Malaria Day, ACREME lead Investigator and Doherty Institute laboratory head Stephen Rogerson outlined the challenges…
New study identifies targets and mechanisms of protective immunity against malaria in children
February 18, 2019
A comprehensive study led by Prof. James Beeson and Dr Linda Reiling, recently published in Nature Communications, has identified key…
Seed grants awarded to ACREME researchers for novel pilot projects
January 17, 2019
In November 2018, project proposals were accepted in a second round of ACREME seed grants, aimed at promoting collaborative research…
Melbourne PhD student Zoe Liu visits Mahidol Vivax Research Unit, Bangkok
November 1, 2018
By Zoe Liu For every PhD student who studies population health, we dream of travelling to countries where our disease…
First round of ACREME Seed Grants Awarded
October 11, 2018
ACREME Seed Grants are aimed at funding collaborative pilot research projects that fall within the centre’s themes of malaria surveillance,…
New study reveals how artemisinin kills malaria parasites
September 25, 2018
In a study recently published in Nature Communications, Professor Leann Tilley and her team at University of Melbourne revealed how…
Four ACREME Fellows give their wrap up of the Malaria World Congress
September 3, 2018
BMC Medicine recently spoke to ACREME Fellows Sarah Charnaud, Julia Cutts, Angela Devine and Herbert Opi, to get their perspectives…
New study reveals revised drug dosing could lead to a better result for vivax malaria patients
July 30, 2018
A recent collaborative study by the WorldWide Antimalarial Resistance Network (WWARN), published in Lancet Infectious Diseases, has important implications for…
Tafenoquine approved by US FDA for radical cure of vivax malaria
July 30, 2018
On 20 July 2018, GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) announced that The United States Food and Drug…